Cleared Traditional

K772179 - EMIT ANTIEPILEPTIC DRUG ASSAYS

K772179 is the FDA 510(k) clearance for EMIT ANTIEPILEPTIC DRUG ASSAYS by Syva Co.. It is a Class 2 Toxicology device (product code DIP) cleared through the Traditional 510(k) pathway after a 27-day FDA review.

K772179 · Syva Co. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1977
Decision
27d
Days
Class 2
Risk

K772179 is an FDA 510(k) clearance for the EMIT ANTIEPILEPTIC DRUG ASSAYS. Classified as Enzyme Immunoassay, Diphenylhydantoin (product code DIP), Class II - Special Controls.

Submitted by Syva Co. (Walker, US). The FDA issued a Cleared decision on December 20, 1977 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3350 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Syva Co. devices

Submission Details

510(k) Number K772179 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 23, 1977
Decision Date December 20, 1977
Days to Decision 27 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 87d · This submission: 27d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DIP Enzyme Immunoassay, Diphenylhydantoin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3350
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DIP Enzyme Immunoassay, Diphenylhydantoin

All 36
Devices cleared under the same product code (DIP) and FDA review panel - the closest regulatory comparables to K772179.
EMIT AED PHENYTOIN ASSAY
K832033 · Syva Co. · Aug 1983
VIRGO IPA FOR DETECTION OF PHENYTOIN
K811745 · Electro-Nucleonics Laboratories, Inc. · Jul 1981
ANALYZER, EMIT AED ASSAYS TO CENTRIFICHE
K780218 · Syva Co. · Mar 1978
PHENYTOIN ANALYTICAL TEST PACKS
K771233 · E.I. Dupont DE Nemours & Co., Inc. · Jul 1977